Freshly Printed - allow 10 days lead
Couldn't load pickup availability
Emerging Technologies for Heart Diseases
Volume 2: Treatments for Myocardial Ischemia and Arrhythmias
Comprehensive reference on emerging medical technologies and their implications for cardiovascular issues, including myocardial ischemia and arrhythmias
Udi Nussinovitch (Edited by)
9780128137048, Elsevier Science
Hardback, published 19 August 2020
730 pages
27.6 x 21.5 x 3.8 cm, 1.79 kg
"This second volume provides excellent, in-depth information on state-of-the-art techniques and emerging innovations in various cardiovascular procedures such as coronary angioplasty, stenting and bioabsorbable scaffolds, atherectomy, mechanical thrombectomy, treatment of chronic total occlusions, left atrial appendage closure, and embolic protection devices. The quality and content of this book is exceptional. The book is ideal for physicians and researchers in the advanced stages of cardiovascular training." --Doody Reviews
The increasing pace of advances in cardiology throughout the last few decades has fundamentally altered the natural course of heart patients. In the last few years, available therapies have been revolutionized completely by new transcatheter therapeutic approaches, novel ventricular assist devices, and new drugs. Also, molecular biology and genetics have a rapidly growing impact on cardiovascular diseases, enabling the field of regenerative medicine to become increasingly closer to routine clinical implementation. Emerging Technologies for Heart Diseases was conceived to cover the recent extensive literature on current and novel therapeutic options for cardiac patients. The first volume is dedicated to heart failure and valvular disorders, and the second covers myocardial ischemia and arrhythmias. The clinical topic is addressed in several chapters divided according to the therapeutic approach (mechanical or electrical device-based, or cell and gene-based). Each of the 46 chapters focuses on clinically available solutions, new therapies currently under evaluation in clinical trials, promising preclinical technologies, and emerging concepts and innovations that have not yet been tested in a preclinical model. Also, the book discusses future challenges and opportunities for clinical implementation. Lessons learned from abandoned experimental practices are also covered, giving the readers the widest possible perspective of current therapeutic dilemmas. Overall, this textbook was designed for physicians who want to stay up-to-date with current therapies and those of the future, for biomedical companies, and for those who wish to broaden their knowledge of new cardiovascular therapeutic options.
SECTION 5: Treatment of ischemic heart disease 24. Coronary Balloon Angioplasty, Stenting, and Bioabsorbable Scaffolds 25. Coronary thrombectomy 26. Coronary atherectomy and treatments for calcified coronary lesions 27. Treatment of chronic total occlusion 28. Minimally-invasive device-based approaches for improving cardiac perfusion 29. Gene therapy approaches to cardiac neovascularization and protection from ischemia SECTION 6: Treatment and prevention of ventricular tachyarrhythmias 30. The past, present and future of implantable electrical defibrillators 31. Electrophysiological mapping and cardiac ablation therapy for the prevention of ventricular arrhythmias 32. Gene and cell therapy approaches for the prevention and treatment of ventricular arrhythmia SECTION 7: Treatment and prevention of supraventricular tachyarrhythmias 33. Ablation therapy and implantable device-based approaches for supraventricular arrhythmias 34. Gene and cell-based therapies for the prevention and treatment of supraventricular arrhythmias SECTION 8: Treatment and prevention of bradyarrhythmias 35. Cardiac rhythm devices of today and tomorrow 36. Molecular therapies for bradyarrhythmias 37. Cell therapy approaches for treatment of bradyarrhythmias 38. Optogenetics for cardiac pacing and termination of arrhythmias 39. Non-optognetic approaches for leadless cardiac pacing SECTION 9: Flexible electronics for cardiac monitoring and therapy 40. Organ Conformal Electronics for Cardiac Therapeutics SECTION 10: Device-based therapies for prevention of cerebral embolization 41. Embolic protection devices for stroke prevention during cardiac interventions 42. Percutaneous closure of the left atrial appendage for stroke prevention 43. Devices for continuous embolic protection SECTION 11: Noninvasive methods for structural heart defects 44. Transcatheter closure of atrial septal defect in adults 45. Catheter-based treatments for ventricular septal defects SECTION 12: Novel treatments for hypertension 46. Non-pharmacological therapies for uncontrolled hypertension
Subject Areas: Life sciences: general issues [PSA], Cardiovascular medicine [MJD]
